ABO-话题@MedSci

#ABO#

270篇内容 | 2050人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1597917, encodeId=f5a6159e917ab, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Cell Metabolism：运动减肥新解：白色脂肪组织变成褐色脂肪组织, objectType=article, longId=31379, objectId=e4ca313e9f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4ca313e9f1, replyNumber=0, likeNumber=28, createdTime=2014-03-03, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4ca313e9f1, moduleTitle=Cell Metabolism：运动减肥新解：白色脂肪组织变成褐色脂肪组织, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4ca313e9f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1597916, encodeId=d1b7159e916b7, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=JCO:Cabozantinib显著改善甲状腺髓样癌生存, objectType=article, longId=24255, objectId=5e7f2425596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e7f2425596, replyNumber=0, likeNumber=32, createdTime=2013-09-13, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e7f2425596, moduleTitle=JCO:Cabozantinib显著改善甲状腺髓样癌生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e7f2425596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1597915, encodeId=f978159e915bf, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Cell Metabolism：高胰岛素水平可导致肥胖, objectType=article, longId=13474, objectId=c3fd134e417, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3fd134e417, replyNumber=0, likeNumber=33, createdTime=2012-12-22, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3fd134e417, moduleTitle=Cell Metabolism：高胰岛素水平可导致肥胖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3fd134e417)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1597914, encodeId=b1c9159e914fe, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=JCO：Cabozantinib或可改善晚期前列腺癌患者PFS, objectType=article, longId=12842, objectId=ba8612842b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba8612842b3, replyNumber=0, likeNumber=29, createdTime=2012-12-12, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba8612842b3, moduleTitle=JCO：Cabozantinib或可改善晚期前列腺癌患者PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba8612842b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1597913, encodeId=8b55159e913c0, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=FDA批准cabozantinib用于治疗甲状腺髓样癌, objectType=article, longId=12099, objectId=ae9712099e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae9712099e3, replyNumber=0, likeNumber=38, createdTime=2012-12-01, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae9712099e3, moduleTitle=FDA批准cabozantinib用于治疗甲状腺髓样癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae9712099e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1597912, encodeId=b4d8159e9128d, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=FDA授予Exelixis公司抗癌药cabozantinib优先审查资格, objectType=article, longId=8446, objectId=1a8f844619, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a8f844619, replyNumber=0, likeNumber=32, createdTime=2012-08-03, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a8f844619, moduleTitle=FDA授予Exelixis公司抗癌药cabozantinib优先审查资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a8f844619)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1597911, encodeId=fc9c159e911f8, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Cell Metabolism：激素治疗糖尿病,激素, objectType=article, longId=7673, objectId=2228e673d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2228e673d8, replyNumber=0, likeNumber=30, createdTime=2012-07-08, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2228e673d8, moduleTitle=Cell Metabolism：激素治疗糖尿病,激素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2228e673d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1597910, encodeId=5643159e910d9, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Nat Rev Cancer：脱去oncometabolite的面具, objectType=article, longId=5199, objectId=3471519975, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3471519975, replyNumber=0, likeNumber=26, createdTime=2012-04-15, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3471519975, moduleTitle=Nat Rev Cancer：脱去oncometabolite的面具, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3471519975)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1597909, encodeId=9565159e909d0, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=Cell Metabolism：延胡索酸盐可降低心脏病危害, objectType=article, longId=4251, objectId=9d8b425172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d8b425172, replyNumber=0, likeNumber=32, createdTime=2012-03-11, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d8b425172, moduleTitle=Cell Metabolism：延胡索酸盐可降低心脏病危害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d8b425172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1597908, encodeId=b823159e908e0, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, objectTitle=实验动物学(Laboratory Animal Science)词汇, objectType=article, longId=357, objectId=fa4f35e6a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa4f35e6a, replyNumber=0, likeNumber=30, createdTime=2010-07-05, rootId=0, userName=闆锋旦, userId=b6c918580135, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa4f35e6a, moduleTitle=实验动物学(Laboratory Animal Science)词汇, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa4f35e6a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ABO

2020-05-29

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Cell Metabolism：运动减肥新解：白色脂肪组织变成褐色脂肪组织

2014-03-03

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

JCO:Cabozantinib显著改善甲状腺髓样癌生存

2013-09-13

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Cell Metabolism：高胰岛素水平可导致肥胖

2012-12-22

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

JCO：Cabozantinib或可改善晚期前列腺癌患者PFS

2012-12-12

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

FDA批准cabozantinib用于治疗甲状腺髓样癌

2012-12-01

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

FDA授予Exelixis公司抗癌药cabozantinib优先审查资格

2012-08-03

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Cell Metabolism：激素治疗糖尿病,激素

2012-07-08

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Nat Rev Cancer：脱去oncometabolite的面具

2012-04-15

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

Cell Metabolism：延胡索酸盐可降低心脏病危害

2012-03-11

闆锋旦 (审核中...)

前往app查看评论内容

#ABO#

实验动物学(Laboratory Animal Science)词汇

2010-07-05

科室
- - 订阅+
  - 更多科室
工具
服务